Bionext snags Rhenovia team, tech for cell signaling prediction subsidiary

July 7, 2016

Press Release from FierceBiotech

Bionext has picked up cell signaling modeling technology and the R&D team that developed it from Rhenovia Pharma. The arrangement has spawned the creation of TheraScape, a Bionext subsidiary focused on developing a platform capable of predicting what will happen when a drug interacts with a G-protein-coupled receptor (GPCR).

See more: Source